SCHEMBL18159929

SCHEMBL18159929

C=C(c1ccc(O)cc1)c1cccc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.50
MAPT P10636 1/20 0.50
HTT P42858 1/20 0.50
HSD17B10 Q99714 1/20 0.50
GPR55 Q9Y2T6 1/20 0.50
DEGS1 O15121 1/20 0.50
PTK2B Q14289 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NR4A1 P22736 1/20 0.46
NR4A2 P43354 1/20 0.46
NR4A3 Q92570 1/20 0.46
ALDH1A1 P00352 2/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CYP1A2 P05177 1/20 0.42
HDAC8 Q9BY41 2/20 0.42
MMP3 P08254 1/20 0.42
PTPN1 P18031 1/20 0.41
CDC25B P30305 1/20 0.41
PLK1 P53350 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1933651 0.86 NR4A1 (0.55) MAPTHTTHSD17B10PTK2BL3MBTL1
SCHEMBL31371895 0.86 NR4A1 (0.55) MAPTHTTHSD17B10PTK2BL3MBTL1
SCHEMBL7152744 0.84 ALDH1A1 (0.51) PTK2BL3MBTL1NR4A1NR4A2NR4A3
SCHEMBL20773217 0.84 SMN1; SMN2 (0.58) MAPTHTTPTK2BL3MBTL1NR4A1
SCHEMBL10936761 0.82 MAPT (0.67) GFERMAPTHTTHSD17B10GPR55
SCHEMBL1869296 0.82 PTK2B (0.59) MAPTHSD17B10DEGS1PTK2BL3MBTL1
SCHEMBL5495087 0.80 PTK2B (0.46) MAPTHTTHSD17B10DEGS1PTK2B
SCHEMBL3164058 0.80 ALDH1A1 (0.55) MAPTHSD17B10PTK2BL3MBTL1NR4A1
SCHEMBL16549911 0.80 RAB9A (0.51) MAPTPTK2BL3MBTL1ALDH1A1HPGD
SCHEMBL19446360 0.79 DEGS1 (0.51) GFERDEGS1PTK2BL3MBTL1NR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160304442-A1 ARYL NAPHTHYL METHANONE OXIME(S) AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304442-A1 ARYL NAPHTHYL METHANONE OXIME(S) AND PROCESS FOR PREPARATION THEREOF MCL1, CYP11B1, CYP21A2 GFER 1662/4885MAPT 3740/4885HTT 3340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.